authors
- Cho, Y K
- Benson, D M
- Efebera, Y A
- Ashley E. Rosko, MD
- Devine, S M
- Poi, M
- Hofmeister, C C
- Phelps, M A
- Sborov, D W
- Lamprecht, M
- Li, J
- Wang, J
- Hade, E M
- Gao, Y
- Tackett, K
- Williams, N
Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2017
published in
has subject area
- Adult
- Aged
- Antineoplastic Agents, Alkylating
- Combined Modality Therapy
- Creatinine
- Cryotherapy
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Large Neutral Amino Acid-Transporter 1
- Male
- Melphalan
- Middle Aged
- Multiple Myeloma
- Polymorphism, Genetic
- Stomatitis
- Survival Rate
- Time Factors